“…EGPA is considered a systemic disease; however, limited expressions of EGPA confined to the upper or lower respiratory tract may occur. ANCA with a perinuclear immunofluorescence staining pattern is positive in only about 40-60% of patients [48]. Those with ANCA were more likely to have definitive features or surrogates of small-vessel vasculitis, purpura, peripheral neuropathy, myalgia, arthralgia, and glomerulonephritis [54], whereas those without ANCA developed myocarditis, lung infiltrates, and gastrointestinal symptoms frequently.…”